The biodegradable hemostat market size has grown rapidly in recent years. It will grow from $0.97 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to reliance on conventional non-absorbable hemostats, growing surgical procedure volumes, increasing hospital infrastructure, rising awareness of blood loss management, adoption of basic wound care technologies.
The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in polymer and biomaterial science, growth in minimally invasive surgical procedures, rising trauma and emergency cases, increasing regulatory approvals for biodegradable devices, expansion of ambulatory surgical centers. Major trends in the forecast period include rising adoption of absorbable hemostatic products, growing preference for biocompatible and bioabsorbable materials, increasing use in minimally invasive and laparoscopic surgeries, expansion of advanced hemostats in trauma and emergency care, higher demand for ready-to-use and easy-to-apply hemostats.
The rising number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market in the coming years. Surgical procedures are medical interventions carried out by healthcare professionals using specialized instruments to treat, repair, or remove parts of the body for health-related reasons. The growth in surgical procedures is primarily due to the increasing prevalence of chronic conditions, which often require surgical intervention to manage health problems and enhance patient outcomes. Biodegradable hemostats provide a benefit in surgeries, as they naturally degrade within the body after use, eliminating the need for removal and reducing the risk of post-surgical complications. For example, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following a growth of around 42% in 2023. Colorectal procedures contributed the largest share of additional volume in both years. Consequently, the increasing number of surgical procedures is fueling the growth of the biodegradable hemostat market.
Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.
In March 2023, Medtrade Products Ltd, a UK-based biotechnology firm specializing in haemostasis, wound care, and trauma solutions, collaborated with Laubscher and Co AG to launch the CELOX PPH uterine haemostatic tamponade solution throughout Switzerland to tackle postpartum haemorrhage. Through this partnership, Medtrade aims to broaden access to its advanced haemostat technologies, enhance its presence in the Swiss market, and contribute to better maternal outcomes through rapid and effective bleeding management. Laubscher and Co AG is a Switzerland-based medical device company focusing on surgical and women’s health solutions.
Major companies operating in the biodegradable hemostat market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Baxter International Inc, Meril Life Sciences Pvt Ltd, Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc, Axio Biosolutions Pvt Ltd, Biom Up Inc.
North America was the largest region in the biodegradable hemostat market in 2025. The regions covered in the biodegradable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biodegradable hemostat market by increasing costs for imported raw materials such as natural polymers, synthetic biomaterials, and specialized manufacturing inputs. Product segments like composite and synthetic polymer-based hemostats are most affected, particularly in Asia-Pacific and Europe where cross-border sourcing is common. These cost pressures have influenced pricing and supply chain strategies for manufacturers. However, tariffs have also encouraged local sourcing, domestic production, and innovation in alternative biodegradable materials, supporting long-term market growth.
The biodegradable hemostat market research report is one of a series of new reports that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body’s natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.
The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.
The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in polymer and biomaterial science, growth in minimally invasive surgical procedures, rising trauma and emergency cases, increasing regulatory approvals for biodegradable devices, expansion of ambulatory surgical centers. Major trends in the forecast period include rising adoption of absorbable hemostatic products, growing preference for biocompatible and bioabsorbable materials, increasing use in minimally invasive and laparoscopic surgeries, expansion of advanced hemostats in trauma and emergency care, higher demand for ready-to-use and easy-to-apply hemostats.
The rising number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market in the coming years. Surgical procedures are medical interventions carried out by healthcare professionals using specialized instruments to treat, repair, or remove parts of the body for health-related reasons. The growth in surgical procedures is primarily due to the increasing prevalence of chronic conditions, which often require surgical intervention to manage health problems and enhance patient outcomes. Biodegradable hemostats provide a benefit in surgeries, as they naturally degrade within the body after use, eliminating the need for removal and reducing the risk of post-surgical complications. For example, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following a growth of around 42% in 2023. Colorectal procedures contributed the largest share of additional volume in both years. Consequently, the increasing number of surgical procedures is fueling the growth of the biodegradable hemostat market.
Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.
In March 2023, Medtrade Products Ltd, a UK-based biotechnology firm specializing in haemostasis, wound care, and trauma solutions, collaborated with Laubscher and Co AG to launch the CELOX PPH uterine haemostatic tamponade solution throughout Switzerland to tackle postpartum haemorrhage. Through this partnership, Medtrade aims to broaden access to its advanced haemostat technologies, enhance its presence in the Swiss market, and contribute to better maternal outcomes through rapid and effective bleeding management. Laubscher and Co AG is a Switzerland-based medical device company focusing on surgical and women’s health solutions.
Major companies operating in the biodegradable hemostat market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Baxter International Inc, Meril Life Sciences Pvt Ltd, Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc, Axio Biosolutions Pvt Ltd, Biom Up Inc.
North America was the largest region in the biodegradable hemostat market in 2025. The regions covered in the biodegradable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biodegradable hemostat market by increasing costs for imported raw materials such as natural polymers, synthetic biomaterials, and specialized manufacturing inputs. Product segments like composite and synthetic polymer-based hemostats are most affected, particularly in Asia-Pacific and Europe where cross-border sourcing is common. These cost pressures have influenced pricing and supply chain strategies for manufacturers. However, tariffs have also encouraged local sourcing, domestic production, and innovation in alternative biodegradable materials, supporting long-term market growth.
The biodegradable hemostat market research report is one of a series of new reports that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body’s natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.
The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.
The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biodegradable Hemostat Market Characteristics
3. Biodegradable Hemostat Market Supply Chain Analysis
4. Global Biodegradable Hemostat Market Trends and Strategies
5. Biodegradable Hemostat Market Analysis of End Use Industries
7. Global Biodegradable Hemostat Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biodegradable Hemostat Total Addressable Market (TAM) Analysis for the Market
9. Biodegradable Hemostat Market Segmentation
10. Biodegradable Hemostat Market Regional and Country Analysis
11. Asia-Pacific Biodegradable Hemostat Market
12. China Biodegradable Hemostat Market
13. India Biodegradable Hemostat Market
14. Japan Biodegradable Hemostat Market
15. Australia Biodegradable Hemostat Market
16. Indonesia Biodegradable Hemostat Market
17. South Korea Biodegradable Hemostat Market
18. Taiwan Biodegradable Hemostat Market
19. South East Asia Biodegradable Hemostat Market
20. Western Europe Biodegradable Hemostat Market
21. UK Biodegradable Hemostat Market
22. Germany Biodegradable Hemostat Market
23. France Biodegradable Hemostat Market
24. Italy Biodegradable Hemostat Market
25. Spain Biodegradable Hemostat Market
26. Eastern Europe Biodegradable Hemostat Market
27. Russia Biodegradable Hemostat Market
28. North America Biodegradable Hemostat Market
29. USA Biodegradable Hemostat Market
30. Canada Biodegradable Hemostat Market
31. South America Biodegradable Hemostat Market
32. Brazil Biodegradable Hemostat Market
33. Middle East Biodegradable Hemostat Market
34. Africa Biodegradable Hemostat Market
36. Biodegradable Hemostat Market Competitive Landscape and Company Profiles
37. Biodegradable Hemostat Market Other Major and Innovative Companies
40. Biodegradable Hemostat Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biodegradable Hemostat Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biodegradable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biodegradable hemostat? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable hemostat market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Natural Polymer-Based Hemostats; Synthetic Polymer-Based Hemostats; Composite Hemostats; Cellulose-Based Hemostats; Gelatin-Based Hemostats2) By Formulation: Powdered Hemostats; Granular Hemostats; Liquid Hemostats; Foam Hemostats; Film Or Sheet Hemostats
3) By Application: Surgical Procedures; Trauma Procedures; Dental Procedures; Laparoscopic Procedures; Other Applications
4) By Distribution Channel: Direct Sales; Distributors; E-Commerce Platforms; Pharmaceutical Retailers; Healthcare Supply Companies
5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Research Laboratories; Other End Users
Subsegments:
1) By Natural Polymer-Based Hemostats: Collagen-Based; Chitosan-Based; Alginate-Based; Fibrin-Based; Dextran-Based2) By Synthetic Polymer-Based Hemostats: Polyethylene Glycol (PEG)-Based; Polyurethane-Based; Polylactic Acid (PLA)-Based; Polyglycolic Acid (PGA)-Based; Polycaprolactone (PCL)-Based
3) By Composite Hemostats: Natural-Synthetic Polymer Blends; Polymer-Cellulose Composites; Polymer-Gelatin Composites; Multi-Layer Composites; Nano-Composite Hemostats
4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC); Microcrystalline Cellulose (MCC); Carboxymethyl Cellulose (CMC); Nanocellulose-Based; Hydroxypropyl Cellulose (HPC)
5) By Gelatin-Based Hemostats: Porcine Gelatin-Based; Bovine Gelatin-Based; Fish Gelatin-Based; Cross-Linked Gelatin; Modified Gelatin Formulations
Companies Mentioned: Johnson And Johnson Services Inc; Medtronic Plc; Stryker Corporation; Baxter International Inc; Meril Life Sciences Pvt Ltd; Samyang Holdings Corp; Molnlycke Health Care AB; GELITA Medical GmbH; B Braun Melsungen AG; Tricol Biomedical Inc; Hemostasis LLC; Cura Medical; RevMedx Inc; Speed Care Mineral GmbH; Regenity; C R Bard Inc; Integra LifeSciences Corporation; Advanced Medical Solutions Group plc; Anika Therapeutics Inc; Marine Polymer Technologies Inc; Axio Biosolutions Pvt Ltd; Biom Up Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biodegradable Hemostat market report include:- Johnson And Johnson Services Inc
- Medtronic Plc
- Stryker Corporation
- Baxter International Inc
- Meril Life Sciences Pvt Ltd
- Samyang Holdings Corp
- Molnlycke Health Care AB
- GELITA Medical GmbH
- B Braun Melsungen AG
- Tricol Biomedical Inc
- Hemostasis LLC
- Cura Medical
- RevMedx Inc
- Speed Care Mineral GmbH
- Regenity
- C R Bard Inc
- Integra LifeSciences Corporation
- Advanced Medical Solutions Group plc
- Anika Therapeutics Inc
- Marine Polymer Technologies Inc
- Axio Biosolutions Pvt Ltd
- Biom Up Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.08 Billion |
| Forecasted Market Value ( USD | $ 1.63 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
